Source: Pediatric Rheumatology. Unidades: FM, ICB
Subjects: IMUNOLOGIA, INTERLEUCINA 1, MUTAÇÃO GENÉTICA, ANTICORPOS MONOCLONAIS, INFLAMAÇÃO, OSTEOMIELITE, SEQUENCIAMENTO GENÉTICO, HORMÔNIOS DO CÓRTEX ADRENAL, ANTI-INFLAMATÓRIOS
ABNT
MENDONÇA, Leonardo Oliveira et al. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA). Pediatric Rheumatology, v. 18, p. 5 , 2020Tradução . . Disponível em: https://doi.org/10.1186/s12969-020-00454-5. Acesso em: 08 out. 2024.APA
Mendonça, L. O., Grossi, A., Caroli, F., Oliveira, R. A. de, Kalil Filho, J. E., Castro, F. F. M., et al. (2020). A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA). Pediatric Rheumatology, 18, 5 . doi:10.1186/s12969-020-00454-5NLM
Mendonça LO, Grossi A, Caroli F, Oliveira RA de, Kalil Filho JE, Castro FFM, Pontillo A, Ceccherini I, Barros MAMT, Gattorno M. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA) [Internet]. Pediatric Rheumatology. 2020 ; 18 5 .[citado 2024 out. 08 ] Available from: https://doi.org/10.1186/s12969-020-00454-5Vancouver
Mendonça LO, Grossi A, Caroli F, Oliveira RA de, Kalil Filho JE, Castro FFM, Pontillo A, Ceccherini I, Barros MAMT, Gattorno M. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA) [Internet]. Pediatric Rheumatology. 2020 ; 18 5 .[citado 2024 out. 08 ] Available from: https://doi.org/10.1186/s12969-020-00454-5